EF
Insider
Equity AB Frankenius
10% ownerEquity AB Frankenius (10% owner) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in TriSalus Life Sciences, Inc. (TLSI). Across 1 priced purchase filing, the average 21-session return was +22.3% from execution and +27.3% from disclosure (delay-adjusted; derived). The largest single filing was $250K of TLSI (62,972 sh × $3.97, as filed), executed Dec 17 2024.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+22.3%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+27.3%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$250K
shares × price, as filed
Last traded
Dec 17 2024
Filed Dec 19 2024
Volume by month
Buys $250K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
TLSIRecent filings
TLSIPURCHASE
TriSalus Life Sciences, Inc.
View filing →
$250K62,972 sh × $3.97
Exec Dec 17 2024
Filed Dec 19 2024 · 5:30 PM ET